Back to search

Article

DLK1 downregulation serves as a potential biomarker for disease severity and a therapeutic target in bronchiectasis

2025-07-29

Abstract excerpt

<title>Abstract</title> <p> Background The pathological mechanisms underlying bronchiectasis remain incompletely understood, necessitating novel therapeutic targets. Delta-like homolog 1 (DLK1), a Notch pathway regulator, plays critical roles in tissue repair and inflammation modulation, yet its regulatory role in bronchiectasis pathogenesis remains undefined. Methods This study integrated cis-expression quantit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6176a5dc-1938-527f-b63c-0c2f7ea5df94
DOI
10.21203/rs.3.rs-7090713/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DLK1 downregulation serves as a potential biomarker for disease severity and a therapeutic target in bronchiectasisDOI 10.21203/rs.3.rs-7090713/v1
Select a neighboring publication to make it the new centre.